Retina Research

Emory Eye Center and principal investigator Baker Hubbard, MD will compare Lucentis and Avastin, two anti-VEGF drugs used to treat wet age-related macular degeneration in fixed versus variable dosing. This important trial puts the drugs head-to-head in the first trial of its kind.

Current retina trials   »